• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首要的是不伤害:确定迷幻疗法潜在危害的责任

Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment.

作者信息

Ghaznavi Sharmin, Ruskin Jeremy N, Haggerty Stephen J, King Franklin, Rosenbaum Jerrold F

机构信息

Department of Psychiatry, Center for the Neuroscience of Psychedelics, Massachusetts General Hospital, Boston (Ghaznavi, King, Rosenbaum); Department of Cardiology, Massachusetts General Hospital, Boston (Ruskin); Department of Psychiatry and Neurology, Chemical Neurobiology Laboratory, Center for the Neuroscience of Psychedelics, Massachusetts General Hospital, Boston (Haggerty); Havard Medical School, Boston (Ghaznavi, Ruskin, Haggerty, King, Rosenbaum).

出版信息

Am J Psychiatry. 2025 Jan 1;182(1):47-53. doi: 10.1176/appi.ajp.20230914.

DOI:10.1176/appi.ajp.20230914
PMID:39741443
Abstract

The last few years have seen exponential growth in interest, investment, advocacy, and research into psychedelics as therapeutics. This reflects an optimism about the potential promise of psychedelics as therapeutics. As with all therapeutic interventions, research is needed not only into their benefits but also potential risks. Indeed, when substances with therapeutic potential are scrutinized over time, especially in broad populations with psychiatric and medical comorbidities typically excluded from clinical trials, and applied in less well-regulated or controlled settings, a greater understanding of the cautions emerges. Here, we review the literature on the known and potential harms, including enduring perceptual disturbances; triggering or enhancing the risk for onset of mania or psychosis; overuse, misuse, and dependence; challenging experiences or "bad trips"; risks associated with increased neuroplastic potential; and acute and cumulative cardiovascular effects. Each of these issues is addressed in this review, along with the call for continued research, including recommendations for further research and monitoring.

摘要

在过去几年中,人们对迷幻剂作为治疗药物的兴趣、投资、宣传和研究呈指数级增长。这反映出人们对迷幻剂作为治疗药物的潜在前景持乐观态度。与所有治疗干预措施一样,不仅需要研究它们的益处,还需要研究潜在风险。事实上,随着时间的推移,当对具有治疗潜力的物质进行审查时,尤其是在通常被排除在临床试验之外的患有精神疾病和内科合并症的广泛人群中,并在监管或控制较少的环境中应用时,人们对注意事项有了更深入的了解。在此,我们回顾了关于已知和潜在危害的文献,包括持久的感知障碍;引发或增加躁狂或精神病发作的风险;过度使用、滥用和依赖;具有挑战性的体验或“糟糕的旅程”;与神经可塑性潜力增加相关的风险;以及急性和累积性心血管影响。本综述讨论了上述每个问题,并呼吁继续开展研究,包括进一步研究和监测的建议。

相似文献

1
Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment.首要的是不伤害:确定迷幻疗法潜在危害的责任
Am J Psychiatry. 2025 Jan 1;182(1):47-53. doi: 10.1176/appi.ajp.20230914.
2
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
3
Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms.自然主义使用迷幻剂与精神病性症状和躁狂症状的纵向关联。
Psychol Med. 2025 Mar 31;55:e99. doi: 10.1017/S0033291725000716.
4
Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.迷幻药使用与双相情感障碍——对娱乐性使用及其对心理健康影响的调查。
J Affect Disord. 2025 Mar 15;373:505-511. doi: 10.1016/j.jad.2024.12.044. Epub 2024 Dec 13.
5
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans.评估迷幻药物的滥用潜力,作为人类医疗用途的安全药理学评估的一部分。
Neuropharmacology. 2018 Nov;142:89-115. doi: 10.1016/j.neuropharm.2018.01.049. Epub 2018 Feb 8.
6
Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms.在临床实践中使用迷幻剂:比较治疗用途与潜在危害。
Curr Rev Clin Exp Pharmacol. 2023;18(2):94-109. doi: 10.2174/2772432817666220321142707.
7
Adolescent Psychedelic Use and Psychotic or Manic Symptoms.青少年使用迷幻药与精神病或躁狂症状。
JAMA Psychiatry. 2024 Jun 1;81(6):579-585. doi: 10.1001/jamapsychiatry.2024.0047.
8
The psychedelic effects of cannabis: A review of the literature.大麻的致幻作用:文献综述。
J Psychopharmacol. 2024 Jan;38(1):49-55. doi: 10.1177/02698811231209194. Epub 2023 Nov 10.
9
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.当前对迷幻药物治疗成瘾的临床研究和医学化的观点:安全性、疗效、局限性和挑战。
CNS Drugs. 2024 Oct;38(10):771-789. doi: 10.1007/s40263-024-01101-3. Epub 2024 Jul 20.
10
Psychedelic drug use and schizotypy in young adults.年轻人的迷幻药物使用与精神分裂症特质。
Sci Rep. 2021 Jul 23;11(1):15058. doi: 10.1038/s41598-021-94421-z.

引用本文的文献

1
Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach.基于精神分析的摇头丸辅助治疗病理性自恋:一种新的理论方法。
Front Psychiatry. 2025 Apr 2;16:1529427. doi: 10.3389/fpsyt.2025.1529427. eCollection 2025.